Support for stimulant users to reduce HIV risk
Part of Mental health clinical trials.
This study tests a program to help men who use stimulants and are at risk for HIV reduce drug use and prevent HIV infection. Participants may get access to PrEP, a daily pill that prevents HIV, and support to lower their risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older.
- You are a cisgender man (your gender identity matches your sex at birth).
- You've had sex without a condom with a man in the last 3 months.
- In the last 3 months, you've used at least one stimulant drug (like meth, cocaine, or crack).
- You are HIV-negative (you don't have HIV).
- You can speak English or Spanish, and you are not currently taking PrEP.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a smartphone program to help HIV-negative men who have sex with men reduce meth use and improve PrEP adherence. It explores whether combining support for both behaviors is more effective than addressing them separately.
This study looks at how well a daily HIV prevention pill (F/TAF) works for people who use drugs. It also includes interviews with healthcare providers and peer navigators to understand how to better support patients.
This study tests a program to help men who have sex with men start and stick with PrEP, a daily pill that prevents HIV. It aims to make PrEP easier to use and reduce HIV risk.
This study tests a program to help Black and Hispanic women with substance use disorders take PrEP consistently to prevent HIV. The goal is to see if talking with a health coach can improve PrEP use and reduce HIV risk.
This study tests a new approach to help young gay and bisexual men who take PrEP medication prevent HIV but sometimes miss doses or have condomless sex. It aims to see if behavioral strategies can improve adherence to PrEP and reduce risky behaviors.
This study looks at how feeling judged or stigmatized for being Latino and for using meth may affect your interest in taking PrEP, a daily pill that prevents HIV. The researchers want to understand these experiences to better help men like you stay healthy.
Hear when a new Drug Use Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.